PERKINELMER LAUNCHES POWERFUL NEW DNA FORENSICS WORKSTATION FOR CRIMINAL INVESTIGATION
PerkinElmer, Inc., a global leader in health sciences, announced today the launch of a major new addition to their forensics portfolio, the new MultiPROBE® II Forensic Workstation. The launch of this powerful new integrated system comes on the heels of President George W. Bush signing the “Justice for All Act” that will make post-conviction DNA testing available to anyone declaring their innocence in federal cases. The five-year, $1 billion US program contains substantial funding and incentives for states that adopt similar DNA testing policies and streamline the significant backlog of 350,000 untested DNA evidence samples in various criminal cases. Forensic identification of DNA evidence is becoming increasingly more critical in criminal investigations and felon databasing. According to the Innocence Project, a Cardozo Law School legal board, 151 individuals convicted of serious crimes have been exonerated using DNA evidence.
PerkinElmer’s new forensic workstation will allow the forensic community to increase productivity by up to ten times, eliminate human error, drastically reduce cross-contamination yielding high quality purified human DNA resulting in increased data integrity and traceability.
“The introduction of the MultiPROBE II Forensic Workstation addresses a growing demand for DNA testing technology. With the federal government’s latest commitment to offering comprehensive DNA analysis in post-conviction criminal investigations, we believe our latest technology provides law agencies a powerful new tool,” said Peter Coggins, Ph.D., president of PerkinElmer Life and Analytical Sciences. “PerkinElmer is continuously developing and updating its forensic analysis portfolio so that it remains the preeminent solution provider for investigative laboratories worldwide.”
PerkinElmer’s MultiPROBE II Forensic Workstation reliably performs automated DNA processing procedures including isolation, quantification setup (QPCR), normalization and dilution, and typing PCR setup. This workstation offers industry -leading technology of onboard liquid handling system with the added benefit of bundled forensic application options to provide complete walk-away automation of forensic DNA analysis.
In addition, PerkinElmer provides several other DNA-related forensics products including chemiluminescent visualization using DNA Thunder, Single Nucleotide Polymorphism (SNP) detection system with AcyloPrime terminators and EnVision multimode plate reader and MicroMax reagents with ScanArray reader for most chip-based DNA protocols. The complete suite of forensic products also includes Clarus® Gas Chromatographs (GC) and Gas Chromatographs Mass Spectrometers (GC/MS), TurboMatrix™ Headspace Samplers and Thermal Desorbers, ELAN® Inductively Coupled Plasma Mass Spectrometers (ICP-MS), Diamond DSC/HyperDSC™ Thermal Analyzers, AutoIMAGETM Microscope Systems, Spectrum Spotlight TM 200 FT-IR Microscope Systems, and the Spectrum Spotlight 300 FT-IR Imaging Systems.
PerkinElmer, Inc. is a global technology leader focused in the following businesses – Life and Analytical Sciences, Optoelectronics and Fluid Sciences. Combining operational excellence and technology expertise with an intimate understanding of our customers’ needs, PerkinElmer provides products and services in health sciences and other advanced technology markets that require innovation, precision and reliability. The Company serves customers in more than 125 countries, and is a component of the S&P 500 Index. Additional information is available through www.perkinelmer.com or 1-877-PKI-NYSE.
